News and Events

Latest News

Arquer Diagnostics @Arquer Diagnostics
With our latest #patient #study at an end, we can see results that are extremely consistent with our existing clinical #data. The consistency of our evidence and rigorous nature of our research has made it clear that #ADXBLADDER can replace #cytology in #cancerdiagnosis. https://t.co/PorHLL3LEo

- 6 days ago

2
Arquer Diagnostics @Arquer Diagnostics
#Haematuria, or blood in the urine, can be a leading #symptom of #bladder #cancer. If you've noticed a change in the appearance of your urine, make it a priority to seek advice from a medical professional as soon as possible. https://t.co/Ata5FrRYAi

- 15 days ago

1 2
Arquer Diagnostics @Arquer Diagnostics
#Partnership is a big part of the #Arquer philosophy. This is why we work with many clinicians and groups around Europe on innovative #diagnostic #technologies. https://t.co/boq9ECiISQ

- 25 days ago

1 4
Arquer Diagnostics @Arquer Diagnostics
Those who undergo successful #treatment for #bladder #cancer are at risk of #recurrence for many years afterwards. Routine visits to your urologist are vital to stay on the right path: it's here that #ADXBLADDER can be a really useful tool for the detection of recurrence. https://t.co/wllXtQmQ4v

- 33 days ago

2 4
Arquer Diagnostics @Arquer Diagnostics
4/5 #patients are referred to #urologists due to #haematuria. When #bladdercancer is suspected, #urologists can use #ADXBLADDER in conjunction with #cystoscopic procedures for a more confident and accurate #diagnosis of bladder cancer. https://t.co/w5aGQqfIVQ #Arquer #urology https://t.co/NkYisrtHdV

- 44 days ago

2
arquer diagnostics

Innovation That Never Sleeps

The Start of Non-Invasive Testing When Arquer Diagnostics was set up to research and develop a new innovative urine test ...
Read More

Arquer Diagnostics achieves ISO13485 certification from BSI

In alignment with its commitment to achieving and maintaining excellence for patients, clinicians and all partners. BSI is an internationally ...
Read More

ADXBLADDER: A Novel Non-Invasive Aid for Bladder Cancer Monitoring

The innovative Arquer Diagnostic urine test for bladder cancer adds recurrence monitoring to the approved indications Sunderland, January 22nd 2019 ...
Read More

Arquer CEO Nadia Whittley Named Among Top 50 Female ‘Movers & Shakers’ in BioBusiness Report

Arquer Diagnostics Ltd (“Arquer”), a UK-based company focusing on the development of non-invasive cancer diagnostic tests today announced that CEO ...
Read More